1

Calyxt

Calyxt
Leadership team

Ms. Debra H. Frimerman (Gen. Counsel & Corp. Sec.)

Mr. William F. Koschak (Chief Financial Officer)

Mr. Michael Allen Carr (Pres, CEO & Director)

Products/ Services
Agriculture, Biotechnology, Developer Platform, Food and Beverage, GreenTech, Health Care
Number of Employees
50 - 100
Headquarters
Minnesota City, Minnesota, United States
Established
2010
Company Registration
SEC CIK number: 0001705843
Revenue
2M - 5M
Traded as
CLXT
Social Media
Overview
Location
Summary
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
History

Founded in 2014 in Roseville, Minnesota, Calyxt has assembled a world-class management team and more than 50 years of combined food-industry experience. In addition to the U.S., Calyxt is also building a presence in the European Union (EU) under the Calyxt-Europe name, a wholly-owned subsidiary of the company.

Mission
Our mission is to transform food with vertically integrated gene editing technologies delivering healthier and better-tasting products, with higher-yielding and more sustainable crops, for better, easier and more efficient food production for all.
Vision
Our vision is to become the world leader in healthy and sustainable food solutions.
Key Team

Trina Lundblad (Director of Communications)

Dr. Daniel F. Voytas Ph.D. (Founder, Chief Science Officer & Chair of Scientific Advisory Board)

Dr. Travis J. Frey Ph.D. (Chief Technology Officer)

Dr. Stephen M. Bravo (Chief Medical Officer)

Mr. Gerry Nuovo (Sr. VP of Bus. Devel.)

Ms. Suellen Boot (Bus. Devel. Director)

Recognition and Awards
Calyxt has earned numerous awards for its innovative approach to agriculture, including the 2017 Agrimarine Biotech USDA Small Business Innovation Research award and various awards from the Minnesota High Tech Association, the BioBusiness Alliance of Minnesota, the Midwest Innovative Companies Summit, the Annual International Genetically Engineered Machine Competition, and Artemisia Inc.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Calyxt
Leadership team

Ms. Debra H. Frimerman (Gen. Counsel & Corp. Sec.)

Mr. William F. Koschak (Chief Financial Officer)

Mr. Michael Allen Carr (Pres, CEO & Director)

Products/ Services
Agriculture, Biotechnology, Developer Platform, Food and Beverage, GreenTech, Health Care
Number of Employees
50 - 100
Headquarters
Minnesota City, Minnesota, United States
Established
2010
Company Registration
SEC CIK number: 0001705843
Revenue
2M - 5M
Traded as
CLXT
Social Media